2-[4-(4-Methoxyphenyl)piperazin-1-yl]ethanamine → 1-t-Butyl-3-{2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl}aminomethyl-5-propylpyrazole
Reaktionsgleichung
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][NH2:17])[CH2:11][CH2:10]2)=[CH:5][CH:4]=1.[CH2:18]([C:21]1[N:25]([C:26]([CH3:29])([CH3:28])[CH3:27])[N:24]=[C:23]([CH:30]=O)[CH:22]=1)[CH2:19][CH3:20]>>[C:26]([N:25]1[C:21]([CH2:18][CH2:19][CH3:20])=[CH:22][C:23]([CH2:30][NH:17][CH2:16][CH2:15][N:12]2[CH2:11][CH2:10][N:9]([C:6]3[CH:5]=[CH:4][C:3]([O:2][CH3:1])=[CH:8][CH:7]=3)[CH2:14][CH2:13]2)=[N:24]1)([CH3:29])([CH3:28])[CH3:27]Komponenten
3
Versuchsvorschrift
Compound 38 was prepared using the same method as that of Example 1 except that 4-(4-methoxyphenyl)piperazin-1-ylethylamine and 5-propyl-1-t-butylpyrazole-3-carbaldehyde were used.
Quellen und Nachweise
- ORD-Eintrag
- ord-f640455dadb949eea1ea953cead644a2
- Quelldatensatz
- uspto-grants-2009_06